Cardiovascular Diseases Clinical Trial
To determine the genetics and epidemiology of different types of early familial coronary disease. Accurate markers of major gene syndromes for early coronary disease were identified using a genetic segregation and linkage study of lipids, lipoproteins, apolipoproteins, and DNA probes in 36 large Utah pedigrees.
BACKGROUND:
Heart disease, with coronary heart disease as the main form, and stroke are respectively the
first and third most common causes of death in the Unites States. Hypertension, diabetes,
hyperlipidemia, and cigarette smoking have been demonstrated to be major risk factors for
coronary heart disease and stroke. The first three risk factors have all been suggested to
be determined in some degree by genetic factors.
In 1975 the National Heart and Lung Institute convened a Task Force on Genetic Factors in
Atherosclerotic Disease to review what was known in the field and to identify fruitful
research priorities for future study. The Task Force recommended utilizing existing
genealogical files, sampling and studying large kindreds from a general population,
evaluating both genetic and modifying factors, and encouraging collaborative studies by
epidemiologists, biostatisticians and population geneticists.
The Utah population was well suited for a study of coronary prone pedigrees. The high birth
rate and polygamy in ancestral founders of the state produced very large pedigrees.
Pedigrees were relatively easy to find and trace with available genealogical records.
DESIGN NARRATIVE:
A computer data base of Utah residents was developed which included 1.2 million persons in
genealogical files, 240,000 persons in death certificate files and 120,000 persons in Health
Family Tree questionnaire files. Over 1,400 persons who were members of 21 coronary prone
pedigrees were clinically screened.
Death certificate files were used to identify early coronary deaths which were defined as
before age 55 in men and before age 65 in women. Mail and phone contacts were made to the
surviving offspring, spouses, or siblings of the deceased proband to determine risk factor
profiles for probands and close relatives. Hospital charts were also abstracted to assess
risk factor profiles for probands. Clinical screening of the relatives of coronary probands
were conducted using a detailed protocol assessing all standard coronary risk factors.
Fasting blood tests were obtained for total cholesterol, triglycerides, high density
lipoprotein, apo B, apo A-1, and apo E. At clinical screening, information was obtained on
relationships, dates and places of vital events for the index person, spouse, offspring,
siblings, parents, aunts and uncles, grandparents, grand aunts and uncles, and
great-grandparents. Information was obtained on blood pressure, height, weight,
electrocardiograms, physician's history and physical examination. Information was also
collected on tobacco and alcohol use, hospitalization, medication usage, socioeconomic
status, Type A personality, physical activity, and reproductive history.
Beginning in 1983 the investigators expanded the collection of computerized detailed family
histories from the families of high school students participating in the Health Family
Trees, a required health education course. Using the Health Family Trees, siblings were
identified in which two or more siblings had early coronary heart disease. The information
from the Health Family Trees was validated by contacting affected relatives and by
collecting hospital data. These individuals then attended clinic screening. Detailed
biochemical analyses of blood samples from these individuals were compared to find
abnormalities that occured in both siblings with coronary heart disease and to identify
specific subtypes of inherited early coronary disease. Testing for genetic linkage of DNA
markers for apolipoproteins with these specific abnormalities was also done. Healthy age-sex
matched controls with at least three siblings and no coronary heart disease in siblings or
parents served as controls.
;
N/A
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05650307 -
CV Imaging of Metabolic Interventions
|
||
| Recruiting |
NCT05654272 -
Development of CIRC Technologies
|
||
| Recruiting |
NCT04515303 -
Digital Intervention Participation in DASH
|
||
| Completed |
NCT04056208 -
Pistachios Blood Sugar Control, Heart and Gut Health
|
Phase 2 | |
| Recruiting |
NCT04417387 -
The Genetics and Vascular Health Check Study (GENVASC) Aims to Help Determine Whether Gathering Genetic Information Can Improve the Prediction of Risk of Coronary Artery Disease (CAD)
|
||
| Not yet recruiting |
NCT06211361 -
Cardiac Rehabilitation Program in Patients With Cardiovascular Disease
|
N/A | |
| Not yet recruiting |
NCT06032572 -
Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE)
|
N/A | |
| Recruiting |
NCT04514445 -
The BRAVE Study- The Identification of Genetic Variants Associated With Bicuspid Aortic Valve Using a Combination of Case-control and Family-based Approaches.
|
||
| Enrolling by invitation |
NCT04253054 -
Chinese Multi-provincial Cohort Study-Beijing Project
|
||
| Completed |
NCT03273972 -
INvestigating the Lowest Threshold of Vascular bENefits From LDL Lowering With a PCSK9 InhibiTor in healthY Volunteers
|
N/A | |
| Completed |
NCT03680638 -
The Effect of Antioxidants on Skin Blood Flow During Local Heating
|
Phase 1 | |
| Recruiting |
NCT04843891 -
Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis.
|
Phase 1 | |
| Completed |
NCT04083846 -
Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of High-dose CKD-385 in Healthy Volunteers(Fed)
|
Phase 1 | |
| Completed |
NCT04083872 -
Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of Highdose CKD-385 in Healthy Volunteers(Fasting)
|
Phase 1 | |
| Completed |
NCT03693365 -
Fluid Responsiveness Tested by the Effective Pulmonary Blood Flow During a Positive End-expiratory Trial
|
||
| Completed |
NCT03466333 -
Postnatal Enalapril to Improve Cardiovascular fUnction Following Preterm Pre-eclampsia
|
Phase 2 | |
| Completed |
NCT03619148 -
The Incidence of Respiratory Symptoms Associated With the Use of HFNO
|
N/A | |
| Completed |
NCT04082585 -
Total Health Improvement Program Research Project
|
||
| Completed |
NCT05132998 -
Impact of a Comprehensive Cardiac Rehabilitation Program Framework Among High Cardiovascular Risk Cancer Survivors
|
N/A | |
| Completed |
NCT05067114 -
Solutions for Atrial Fibrillation Edvocacy (SAFE)
|